References
- Kahn HS. The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005; 5:26. https://doi.org/10.1186/1471-2261-5-26
- Kahn HS. The lipid accumulation product is better than BMI for identifying diabetes: a population-based comparison. Diabetes Care. 2006;29(1):151-153. https://doi.org/10.2337/diacare.29.01.06.dc05-1805
- Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev. 2006;2(4):367-373. https://doi.org/10.2174/1573399810602040367
- Freedland ES. Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. Nutr Metab (Lond). 2004;1(1):12. https://doi.org/10.1186/1743-7075-1-12
- Vieira BA, Sauer P, Marcadenti A, Piovesan CH. Association between LAP Index (Lipid Accumulation Product) and metabolic profile in hospitalized patients. Nutr Hosp. 2015;31(6):2771-2774.
- Carneiro Roriz AK, Santana Passos LC, Cunha de Oliveira C, Eickemberg M, de Almeida Moreira P, Ramos Sampaio L. Discriminatory power of indicators predictors of visceral adiposity evaluated by computed tomography in adults and elderly individuals. Nutr Hosp. 2014;29(6):1401-1407.
- Roriz AK, Passos LC, de Oliveira CC, Eickemberg M, Moreira Pde A, Sampaio LR. Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly. PLoS One. 2014;9(7):e103499. https://doi.org/10.1371/journal.pone.0103499
- Nguyen-Duy TB, Nichaman MZ, Church TS, Blair SN, Ross R. Visceral fat and liver fat are independent predictors of metabolic risk factors in men. Am J Physiol Endocrinol Metab. 2003;284(6):E1065-1071. https://doi.org/10.1152/ajpendo.00442.2002
- Sam S, Haffner S, Davidson MH, D'Agostino RB Sr, Feinstein S, Kondos G, et al. Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes. Diabetes Care. 2009;32(10):1916-1920. https://doi.org/10.2337/dc09-0412
- Zainuddin LR, Isa N, Muda WM, Mohamed HJ. The prevalence of metabolic syndrome according to various definitions and hypertriglyceridemic-waist in malaysian adults. Int J Prev Med. 2011;2(4):229-237.
- Amini M, Esmaillzadeh A, Sadeghi M, Mehvarifar N, Amini M, Zare M. The association of hypertriglyceridemic waist phenotype with type 2 diabetes mellitus among individuals with first relative history of diabetes. J Res Med Sci. 2011;16(2):156-164.
- Blackburn P, Lemieux I, Lamarche B, Bergeron J, Perron P, Tremblay G, et al. Hypertriglyceridemic waist: a simple clinical phenotype associated with coronary artery disease in women. Metabolism. 2012;61(1):56-64. https://doi.org/10.1016/j.metabol.2011.05.017
- Ioachimescu AG, Brennan DM, Hoar BM, Hoogwerf BJ. The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study. Obesity (Silver Spring). 2010;18(9):1836-1844. https://doi.org/10.1038/oby.2009.453
- Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98(5):960-967. https://doi.org/10.1111/j.1572-0241.2003.07486.x
- Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC; Public Policy Committee of the American Association for the Study of Liver Disease. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology. 2008;47(4): 1363-1370. https://doi.org/10.1002/hep.22109
- Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34(3):274-285. https://doi.org/10.1111/j.1365-2036.2011.04724.x
- Schindhelm RK, Diamant M, Dekker JM, Tushuizen ME, Teerlink T, Heine RJ. Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev. 2006; 22(6):437-443. https://doi.org/10.1002/dmrr.666
- Despres JP, Cartier A, Cote M, Arsenault BJ. The concept of cardiometabolic risk: bridging the fields of diabetology and cardiology. Ann Med. 2008;40(7):514-523. https://doi.org/10.1080/07853890802004959
- Kallwitz ER, Kumar M, Aggarwal R, Berger R, Layden-Almer J, Gupta N, et al. Ethnicity and nonalcoholic fatty liver disease in an obesity clinic: the impact of triglycerides. Dig Dis Sci. 2008;53(5):1358-1363. https://doi.org/10.1007/s10620-008-0234-x
- Eguchi Y, Eguchi T, Mizuta T, Ide Y, Yasutake T, Iwakiri R, et al. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J Gastroenterol. 2006;41(5):462-469. https://doi.org/10.1007/s00535-006-1790-5
- van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG, et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology. 2008;48(2):449-457. https://doi.org/10.1002/hep.22350
- Ji BL, Li R, Zhang SH, Gong LL, Wang ZH, Ren W, et al. The lipid accumulation product is highly related to serum alanine aminotransferase level in male adults. Nutr Res. 2012;32(8):581-587. https://doi.org/10.1016/j.nutres.2012.06.019
- Dai H, Wang W, Chen R, Chen Z, Lu Y, Yuan H. Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults. Nutr Metab (Lond). 2017;14:49. https://doi.org/10.1186/s12986-017-0206-2
- Deurenberg-Yap M, Chew SK, Deurenberg P. Elevated body fat percentage and cardiovascular risks at low body mass index levels among Singaporean Chinese, Malays and Indians. Obes Rev. 2002;3(3):209-215. https://doi.org/10.1046/j.1467-789X.2002.00069.x
- Bedogni G, Kahn HS, Bellentani S, Tiribelli C. A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterol. 2010;10:98. https://doi.org/10.1186/1471-230X-10-98
- Xiang S, Hua F, Chen L, Tang Y, Jiang X, Liu Z. Lipid accumulation product is related to metabolic syndrome in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2013;121(2):115-118. https://doi.org/10.1055/s-0032-1333261
- Mirmiran P, Bahadoran Z, Azizi F. Lipid accumulation product is associated with insulin resistance, lipid peroxidation, and systemic inflammation in type 2 diabetic patients. Endocrinol Metab (Seoul). 2014;29(4):443-449. https://doi.org/10.3803/EnM.2014.29.4.443
- Moon K, Sung SH, Chang YK, Park IK, Paek YM, Kim SG, et al. The association between Apolipoprotein E genotype and lipid profiles in healthy woman workers. J Prev Med Public Health. 2010;43(3):213-221. https://doi.org/10.3961/jpmph.2010.43.3.213
- Dobbelsteyn CJ, Joffres MR, MacLean DR, Flowerdew G. A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys. Int J Obes Relat Metab Disord. 2001;25(5):652-661. https://doi.org/10.1038/sj.ijo.0801582
- Tellechea ML, Aranguren F, Martinez-Larrad MT, Serrano-Rios M, Taverna MJ, Frechtel GD. Ability of lipid accumulation product to identify metabolic syndrome in healthy men from Buenos Aires. Diabetes Care. 2009;32(7):e85. https://doi.org/10.2337/dc08-2284
- Xia C, Li R, Zhang S, Gong L, Ren W, Wang Z, et al. Lipid accumulation product is a powerful index for recognizing insulin resistance in non-diabetic individuals. Eur J Clin Nutr. 2012; 66(9):1035-1038. https://doi.org/10.1038/ejcn.2012.83
- Shin KA. The clinical implications of hepatic enzymes in metabolically healthy obese men. Korean J Clin Lab Sci. 2017; 49(3):248-255. https://doi.org/10.15324/kjcls.2017.49.3.248
- Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis. 2008;28(4):339-350. https://doi.org/10.1055/s-0028-1091978
- Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol. 2009;50(1):204-210. https://doi.org/10.1016/j.jhep.2008.10.010
- Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med. 2005;11(2): 183-190. https://doi.org/10.1038/nm1166